Results 131 to 140 of about 12,187 (203)

Effect of sugammadex on postoperative pulmonary complications in patients undergoing video-assisted thoracoscopic lung surgery. [PDF]

Front Oncol
Tian L, Wang Y, Bu Y, Wang Y, Che G.
europepmc   +1 more source

Current recommendations for preventing residual neuromuscular blockade. [PDF]

Anesth Pain Med (Seoul)
Lee JE, Jung H.
europepmc   +1 more source

Topical pyridostigmine for ocular myasthenia gravis: a translational hypothesis. [PDF]

Med Hypothesis Discov Innov Ophthalmol
Ing EB, Lim K, Davies NM, Lobenberg R, Harunur Rashid M, Le TS, Rullo J.   +6 more
europepmc   +1 more source

Comparison of the Effects of Glycopyrrolate and Atropine on Postoperative Delirium in Older Adult Patients Undergoing Laparoscopic Colorectal Surgery: A Randomized Controlled Trial. [PDF]

Drug Des Devel Ther
Wu J, Liu J, Wang C, Wu J, Lin Y, Wang G, Zhang S, Ding M, Liang C.   +8 more
europepmc   +1 more source

Ogilvie Syndrome: A Therapeutic Challenge. [PDF]

Cureus
Reis AS, Antunes AR, Santos LR.
europepmc   +1 more source

Protective effects of clinical anticholinergic and anticholinesterase agents against Bungarus multicinctus venom and neurotoxin-rich snake venoms. [PDF]

PLoS Negl Trop Dis
Zhang G, He M, Sun T, Lee WH.
europepmc   +1 more source

When manual disimpaction isn't enough: Case report and review of neostigmine's role in refractory constipation management. [PDF]

JPGN Rep
Mostafavi M, Lee S, Martin V.
europepmc   +1 more source

Neuromuscular block in paediatric patients undergoing airway management: a narrative review. [PDF]

Curr Opin Anaesthesiol
Bonfiglio R, von Eichstedt H, Fuchs A, Disma N, Riva T.   +4 more
europepmc   +1 more source

Breaking the block: Sugammadex as the last resort for refractory vecuronium-induced neuromuscular blockade in a patient receiving hydroxychloroquine. [PDF]

Indian J Anaesth
Verma S, Sarkar S.
europepmc   +1 more source

Sugammadex versus Neostigmine Reversal After Thoracoscopic Thymectomy in Myasthenia Gravis: A Multicenter, Randomized Controlled Trial. [PDF]

Drug Des Devel Ther
Hu C, Liu S, Xi C, Du Y, Su S, Wang Y, Wu L, Chen H, Wang G.   +8 more
europepmc   +1 more source